SampleFacts Secures $1.8M to Revolutionize Blood Sample Collection with Groundbreaking Uppsala University Research

SampleFacts is thrilled to announce that we have successfully raised SEK 1,800,000 in our latest funding round—a monumental step forward in our mission to revolutionize blood sample collection.

Since our inception in 2023 in the innovation hub of Uppsala, Sweden, SampleFacts has been at the forefront of research and development in the medical technology space.

Our technology is rooted in groundbreaking research conducted by Professor Ulf Landegren and Dr Johan Björkstein at Uppsala University, whose work has paved the way for the development of intuitive devices designed to overcome the traditional challenges associated with blood sample collection.

This funding will accelerate our efforts to bring these novel devices to market, ultimately transforming the processes involved in pre-clinical and clinical studies as well as routine healthcare services.

By eliminating the barriers that have long complicated the collection of blood samples, our technology promises simpler, safer, and more efficient procedures that can enhance patient care and streamline research methodologies.

The new capital will be directed toward further product development, rigorous testing protocols to ensure both reliability and ease-of-use, and scaling our manufacturing capabilities to meet emerging global demands.

As we continue to build on our vision, this funding milestone affirms investor confidence in our mission and the transformative potential of our solutions.

We are excited to move forward, working hand-in-hand with researchers, healthcare professionals, and strategic partners to turn our vision into a tangible, life-changing reality—one innovative device at a time.